Imatinib-induced postoperative periorbital purpura: GASP (Gleevec-Associated Surgical Purpura) in a woman with imatinib-treated chronic myelogenous leukemia
[Article]
Anzalone, C Lane; Cohen, Philip R; Kurzrock, Razelle; Cortes, Jorge E
Background: Imatinib mesylate is a selective tyrosine kinase inhibitor used in the treatment of chronic myelogenous leukemia. Ocular side effects of imatinib include periorbital edema, which may become so severe as to obstruct the visual field.
2014
Dermatology Online Journal
20/1
Anzalone, C Lane; Cohen, Philip R; Kurzrock, Razelle; Cortes, Jorge E